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Abstract
In the brain, membrane associated nongenomic steroid receptors can induce fast-acting responses to ion conductance and
second messenger systems of neurons. Emerging data suggest that membrane associated glucocorticoid and
mineralocorticoid receptors may directly regulate synaptic excitability during times of stress when adrenal hormones are
elevated. As the key neuron signaling interface, the synapse is involved in learning and memory, including traumatic
memories during times of stress. The lateral amygdala is a key site for synaptic plasticity underlying conditioned fear, which
can both trigger and be coincident with the stress response. A large body of electrophysiological data shows rapid
regulation of neuronal excitability by steroid hormone receptors. Despite the importance of these receptors, to date, only
the glucocorticoid receptor has been anatomically localized to the membrane. We investigated the subcellular sites of
mineralocorticoid receptors in the lateral amygdala of the Sprague-Dawley rat. Immunoblot analysis revealed the presence
of mineralocorticoid receptors in the amygdala. Using electron microscopy, we found mineralocorticoid receptors expressed
at both nuclear including: glutamatergic and GABAergic neurons and extra nuclear sites including: presynaptic terminals,
neuronal dendrites, and dendritic spines. Importantly we also observed mineralocorticoid receptors at postsynaptic
membrane densities of excitatory synapses. These data provide direct anatomical evidence supporting the concept that, at
some synapses, synaptic transmission is regulated by mineralocorticoid receptors. Thus part of the stress signaling response
in the brain is a direct modulation of the synapse itself by adrenal steroids.
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Introduction
The amygdala, particularly the lateral nucleus, (LA) is
established as a site for the acquisition and storage of conditioned
fear memory and a trigger of the stress response [1–5]. The
expression of conditioned fear includes amygdala dependent
activation of the hypothalamic-pituitary-adrenal (HPA) axis. The
HPA-axis increases blood concentration of corticosterone in
rodents, which in turn feeds back to the brain including the
amygdala where it binds to both mineralocorticoid (MRs) and
glucocorticoid receptors (GRs) [6–8]. In the hippocampus, MR
and GR activation elicits both rapid, non-genomic effects [8-10]
resulting in changes to synaptic transmission. Cytosolic MR and
GR also translocate to the nucleus upon activation, which results
in changes in gene transcription [11–13]. The cellular mechanisms
of MR and GR signaling in the LA are not fully understood.
However, recent evidence suggests the LA likely contains signaling
mechanisms that include both classic nuclear MR and GR
signaling as well as direct signaling from the synapse via
membrane receptors mechanisms [7,8,14,15], which regulates
the fear response and influence fear related behaviors [16–22].
Both MR and GR regulate the acquisition and consolidation of
fearful memories and may be implicated in stress related disorders
[4,23–26]. Behavioral evidence suggests that activation of the MR
and GR may modulate the acquisition and consolidation of fear
memories [8,18,27–33]. Membrane MR (mMR) and GR (mGR)
may also be implicated in the formation of fear memories.
Corticosterone (CORT) conjugated to a high molecular weight
substance (e.g., bovine serum albumin; BSA) [34] prevents CORT
from entering the cell and can be used to study the nongenomic
activity of mMR and mGR [8,10,35–39]. Activating mMR and
mGR via CORT-BSA is known to induce cognitive deficits
including impairing working memory [40]. Rapid elevations in
CORT are also known to impair successful encoding of new
information [41,42], retention [43] and consolidation [44], and
the retrieval of a long-term memory [45].
Electrophysiological evidence suggests the presence of a rapid
membrane MR and GR at both pre- and postsynaptic locations
[8–10,46–53], which rapidly induce changes to synaptic transmis-
sion. Moreover, behavioral and cognitive evidence suggests the
presence of both MR and GR throughout the limbic system,
including the amygdala. While the presence of MR and GR has
been examined in the hippocampus [54,55] to date only one study
has anatomically described the GR in the amygdala and in LA
synapses [7] in adrenal cortex intact animals. No study has
examined the anatomical expression of MR in the LA or in LA
synapses. The purpose of this experiment is to extend available
evidence of GR expression in LA synapses and to provide the first
anatomical evidence that endogenous MR are expressed in LA
neurons and at the synapse. Results from the data described
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suggest the presence of MR at LA synapses placing them in
position to regulate synaptic plasticity underlying the acquisition of
fear memories.
Results
Western Blot Immunoassay
Western blot immunoassay was used to determine the presence of
MR in amygdala nuclei. Two control regions were also included.
First, tissue from the hippocampal formation was included because
it has previously been reported to contain MR [56–58]. Second,
separate tissue from several hypothalamic subnuclei was tested
because it has previously been reported to contain very low to
undetectable MR [56]. Thus the hippocampus and hypothalamus
served as high and low MR control regions, respectively.
Additionally, the specificity of antibodies including any potential
cross-reactivity used in subsequent immuno electron microscope
studies, to MR and GR, was confirmed with the immunoassay.
Immunoassay results revealed the presence of MR in amygdala
tissue. No cross-reactivity of labeling between the GR and MR was
observed. The GR and MR labeling consisted of single bands at
the molecular weights of 116 or 97 kDA, respectively (Fig. 1A). A
two-way ANOVA revealed an interaction of labeled receptors by
brain region for receptor labeling (F (4, 18) = 7.910, p = 0.001).
Subsequent post hoc comparison of the amygdala versus
hypothalamus for the antibody MA1-620 suggests a statistical
trend towards a greater intensity of labeling in the amygdala
(p = .065). There was no difference in the intensity of MR labeling
between the amygdala and hippocampus. A second MR antibody
that binds to the first 18 amino acids of the receptor (rMR1-18
1D5) was compared with the original antibody, which binds
between amino acid sequence 770 and 945. The intensity of
labeling in the amygdala was greater than in the hypothalamus
(p = 0.002) but less than in the hippocampus (p,.001). No
differences in GR were found between any of the brain regions
(Fig. 1B). These data suggest initial evidence that MR are
expressed in amygdala nuclei and that the there was no cross-
reactivity between antibodies.
Light Microscopy
Amygdala neuron immunoreactivity (ir) was qualitatively exam-
ined using the light microscope to confirm the immunoassay results.
GR-ir and MR-ir was revealed in cells throughout the amygdala
sub-regions, including lateral amygdala (LA), the basal nucleus (B),
and central nucleus (Ce), compared to control sections. GR-ir was
observed at the nucleus of principal and inhibitory LA cells (Fig. 2A
and 2E) but also in small dendrites and apparent spines. In contrast,
the MR-ir labeled with the MA1-620 antibody (Fig. 2B and 2F)
were more dispersed and appeared less dense than GR nuclei. MR-
ir was predominately found in perikaryon, the nucleolus, proximal
dendrites, and in apparent dendritic spines (Fig. 2F inset). MR-ir
labeled with the rMR1-18 1D5 [55] antibody revealed MR
scattered throughout both the nucleus and the cell membrane
(Fig. 2C and 2G). Peripherally, MR also appeared in neuropil,
proximal dendrites and apparent dendritic spines (Fig. 2G inset).
We ran additional control analyses using SG chromogen
labeling. The groups consisted of aldosterone (1 mMol) applied
to the antibody MA1-620 or applied to the antibody rMR1-18
1D5, and the peptide (METKGYHSLPEGLDMERR) used to
generate the antibody rMR1-18 1D5 applied to both MR
antibodies. We qualitatively examined tissue preabsorbed with
the peptide or aldosterone and compared this with tissue
incubated in the primary antibody alone (Fig. 3A and 3D). Tissue
incubated with aldosterone and the antibody MA1-620 had the
appearance of reduced labeling. Using Image J (National Institutes
of Health, Bethesda, MD), we quantified the number of cells
labeled in each condition. Tissue sections incubated in aldosterone
(n= 4) (Fig. 3B) were quantitatively compared with sections
incubated in the antibody MA1-620 (n= 3) (Fig. 3A). A significant
reduction in MR labeling was found when tissue was first
incubated in 1 mMol aldosterone (t = 3.341; p = 0.021). Although
a significant decrease in labeling was determined, there appeared
to be a degree of nonspecificity for the antibody (Fig. 3B), which
may be because the antibody was generated from aldosterone-3
and not generated from the receptor itself. Yet both Western blot
data suggest labeling is specific to the MR. We next incubated the
antibody MA1-620 with the peptide used to generate the second
MR antibody (rMR1-18 1D5) (Fig. 3C). We observed no
difference in labeling from the positively labeled MA1-620 tissue,
providing further evidence that the antibody MA1-620 binds to a
different epitope than that of the antibody rMR1-18 1D5.
Qualitative analysis of the antibody rMR1–18 1D5 was also
examined. Compared with tissue incubated in the primary
antibody alone (Fig. 3D), tissue preabsorbed in aldosterone did
not reduce labeling (Fig. 3E), providing further evidence of
specificity of the antibodies. However, preabsorbing the antibody
rMR1–18 1D5 with the peptide used to generate this antibody
completely blocked the antibody from binding to receptors in the
tissue (Fig. 3F). Together the data revealed that tissue incubated
with excessive agonist or the peptide used to generate the
antibodies reduced or prevented observable labeling in their
respective antibodies but not in the opposing antibody, suggesting
specificity of the antibodies to the receptors.
GR and MR Labeling in Nuclear and Extra Nuclear
Structures
Nuclear and perikaryon MR-ir specificity was examined after
confirming the presence of MR in amygdala neurons. Principal
neurons (Fig. 4A–C), GABAergic interneurons (Fig. 5A), and glial
processes in the LA were observed using the transmission electron
microscope (Fig. 5B and 5C). Cell types show characteristics of
GR- and MR-immunoreactivity when compared to controls.
Confirming the light microscopy examination, GR-ir was
Figure 1. Immunoblots of MR and GR in amygdala (Amg),
hippocampal (HC) and hypothalamic (Hyp) nuclei. As indicated
by the representative immunoblots standardized to b-Actin (A) there
was a significant difference in relative density of MR between brain
nuclei (B). GR was equally distributed in all brain regions. (** denotes
p’s,.01).
doi:10.1371/journal.pone.0014344.g001
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expressed more in the nucleus than in the perikaryon. MR-ir
neurons had nuclear labeling with the antibody rMR1–18 1D5,
but not MA1–620 (Fig. 4 and 5A).
Primary antibody omitted control sections were compared with
MR-ir and GR-ir sections and contained little immunoreactivity in
the nucleus or cytosolic organelles. GR-ir was observed on
ribosomes, Golgi apparatus, mitochondria, presynaptic terminals,
and the PSD (Fig. 5B–F). Similarly, MR-ir (with both MA1–620
and rMR1–18 1D5) was observed on ribosomes and Golgi
apparatus, mitochondria, the cellular membrane, postsynaptic
density (PSD), and on both the presynaptic terminal and vesicles
(Fig. 5F). Control sections revealed little immunoreactivity in the
nucleus or cytosolic organelles, suggesting that the primary
antibody labeling was specific to the GR or MR. In sum,
glutamatergic and GABAergic neurons both contained MR-ir and
GR-ir in nuclear and non-nuclear structures. MR-ir appeared
primarily on neuronal cells and appeared to primarily be
expressed in dendrites and in spines but also, with the antibody
rMR1-18 1D5 in the nucleus.
GR and MR Labeling of Asymmetrical Synapses
MR-ir and GR-ir was expressed in pre- and postsynaptic sites.
Qualitative examination of asymmetrical synapses revealed both
GR-ir and MR-ir (MA1–620 and rMR1–18 1D5) at the PSD
(Fig. 6B–D) and MR-ir at the presynaptic terminal (Fig. 6D),
compared to the primary antibody omitted PSD (Fig. 6A).
A quantitative analysis of MR-ir and GR-ir at the PSD was
performed to determine whether immunoreactivity was different
from primary antibody omitted control sections using a relative
measure of gray intensity (Fig. 7A). Two control analyses were ran
to establish that differences in gray intensity at the PSD were due
to the DAB and not influenced by the electron beam intensity or
size of the PSD. First, the gray intensity of each individual image
was examined to ensure an equal distribution of gray. Indirectly,
this also ensured that the intensity of the electron beam was
consistent across each picture. A one-way ANOVA revealed no
significant differences between each condition (p = .554) (Fig. 7B).
The area of the PSD was then examined to ensure that there were
no differences in the size of the area measured. As predicted, there
were no significant differences in PSD size between any of the
groups (p = .219) (Fig. 7C).
Asymmetrical synapses (n = 250) examined across the four
conditions revealed a significant difference between labeled and
unlabeled synapses (F = 39.09; p,.001). Planned contrasts be-
tween the groups revealed a significant difference between the
primary antibody omitted control and both MRs and GR
(t = 10.496; p,.001). No difference between GR and either of
the MR groups (MA1–620 (p = 0.61); or rMR1–18 ID5 (p= 0.77)
(Fig. 7A) was found. There was no significant difference between
the two MR groups (p = .775). Overall, these data provide
quantitative evidence that both MR and GR are in asymmetrical
synapses of LA neurons.
Figure 2. GR and MR labeling in the rat amygdala. (A & E) GR-ir neurons are distributed throughout the amygdala predominately labeling the
nucleus. (B & F) MR-ir (MA1-620) neurons are distributed throughout the amygdala but immunoreactivity is not as dense as GR-ir. Large proximal
dendrites showed immunoreactivity (F inset). (C & G) MR-ir (rMR1-18 1D5) neurons are distributed in amygdala nuclei and cell membrane but do not
appear as densely labeled in perikaryon (G inset). (D & H) Control section shows little immunoreactivity of cells in amygdala or surrounding nuclei.
Scale bars = 200 mm for A–D, 10 mm for D–G and 5 mm for F & G insets. Amygdala nuclei subdivisions B =basal, Ce = central, Lad= lateral (dorsal
division), Lvl = lateral (ventral-lateral), Lvm= lateral (ventral-medial).
doi:10.1371/journal.pone.0014344.g002
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Discussion
This study provides the first anatomical evidence for the
expression of MR in LA synapses. The Western blot immunoassay
data established the presence of MR in amygdala neurons and
ensured no cross-reactivity between antibodies and receptors.
Examination of immunoreactivity using the electron microscope
provided evidence for expression of MR to the nucleus and extra
nuclear sites including synapses of LA neurons. MR-ir was also
observed in glial processes, and in cellular protein generation and
cell respiration machinery including ribosomes, mitochondria, and
Golgi apparatus. MR-ir was observed in the presynaptic terminal
Figure 3. Preabsorbing antibodies with aldosterone or a peptide reduces or blocks visualization. MR-ir controls were established to
ensure specificity of the antibodies. MA1-620 (A) and rMR1-18 1D5 (D) were visualized using SG chromogen. Tissue was incubated with 1 mMol
aldosterone 30 min before addition of primary antibody. Aldosterone reduced observable chromogen visualization in neurons in the LA (B) when
incubated with the antibody MA1-620. No observable difference was found when incubating aldosterone in tissue with the antibody rMR1-18 1D5
(E). Incubating the peptide used to generate the second antibody with the MA1-620 antibody (C) did not produce observable differences in
chromogen visualization. Incubating the peptide in tissue with the antibody rMR1-18 1D5 completely blocked the antibody from binding to tissue (F).
Scale bars = 200 mm for A–F, 5 mm for insets.
doi:10.1371/journal.pone.0014344.g003
Figure 4. GR and MR immunoreactivity in the nucleus and perikaryon. (A) Supporting light level qualitative analysis, immunoreactivity was
observed in the nuclear compartment of GR-ir labeled LA neurons and (B) MR-ir (rMR1-18 1D5) labeled neurons compared to primary antibody
omitted control slices (C). Little immunoreactivity was observed in the nucleus of LA neurons labeled with the MR antibody MA1-620. MR
immunoreactivity with both antibodies was observed on cytosolic structures including the Golgi Apparatus and cell membrane (B). Scale
bars = 500 nm.
doi:10.1371/journal.pone.0014344.g004
Mineralocorticoid Receptors
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(Fig. 6D), on vesicles (Fig. 5F), and within the PSD itself (Fig. 6C
and 6D). Expression of the MRs at both the presynaptic terminal
and the PSD suggest MRs may be positioned to regulate glutamate
release from the presynaptic terminal and also to regulate post
synaptic responses, both of which has been demonstrated by
recent electrophysiological studies [10,52]. These data support a
growing body of evidence for direct regulation of synaptic
transmission during stress mediated by adrenal hormone signaling
[5,8,47,49,51,59].
The classical signaling pathway of hormone receptors is to
translocate into the nucleus where they homodimerize and bind to
hormone response elements thereby modulating gene transcription
[8,51,60,61]. Evidence from studies in neurons suggests gonadal
and adrenal hormone receptors are also membrane associated and
have an additional signaling mechanism, which is nongenomic
and may involve regulation of ion channels and second messengers
systems at membrane and especially synaptic sites [8,14,51]. For
example, the estrogen receptor was first characterized to have
membrane-bound properties in the 1970s by Pietras and Szeko
[62,63]. Likewise, the androgen [64], progesterone, [65,66], and
glucocorticoid [7] receptors have all been previously characterized
as membrane associated hormone receptors. This study is the first
to anatomically demonstrate that the MRs are also membrane
associated.
In order to confirm MR was expressed in the PSD, two
antibodies, which recognize different epitopes of the MR, were
used to visualize the presence of the receptor throughout neurons
and glia of the LA. The MA1-620 antibody recognizes the ligand-
binding site of the MR. When examining the tissue for MR
labeling at the light microscope level, MA1–620 labeled receptors
that were primarily cytosolic (Fig. 2 and Fig. 3). MR-ir was
significantly reduced with the application of 1 mMol aldosterone
(Fig. 3B). The rMR1–18 1D5 antibody recognizes a different
binding site (see Fig. 3D–F) and labeled receptors in the nucleus,
perikaryon, and in neuropil (Fig. 3). The difference in labeling may
be because aldosterone and corticosterone competes for the
ligand-binding site and will displace the antibody if present.
Alternatively, because rMR1–18 1D5 binds to a different epitope
(amino acids 1–18), both active and inactive MR was observed.
MR labeling using both antibodies was also investigated at the
electron microscope level.
MR labeling, as observed in the electron microscope using both
antibodies, was consistent with a fast acting nongenomic mode of
action of the receptors. Both MA1–620 and rMR1–18 1D5
revealed consistent labeling of the synaptic PSD. Moreover,
quantitative gray scale measures of relative intensity of labeling
were not significantly different between antibodies (Fig. 7). This
suggested that at the synapse, receptor recognition by the different
antibodies was not affected by the endogenous ligand. The degree
to which the synaptic MR and are regulated by circulating
corticosterone levels in both intact and adrenalectomized animals
is an important question for future research.
Studies of MR DNA knockout mice suggest that mMR are
encoded by the same genes as their genomic counterparts [10].
However these receptors may undergo a posttranslational
modification that results in membrane translocation [8,67].
Although it remains unknown how the MR becomes membrane
bound, the GR appears to be covalently modified by the insertion
Figure 5. MR-ir in extra nuclear structures. A significant difference between MR-ir with both antibodies and primary antibody omitted control
sections were observed in multiple extra nuclear structures. Although not observed as frequently as principal neuronal structures, GABAergic
interneurons were observed to have immunoreactivity (see comparison with an unlabeled asymmetrical synapse) (A). Glial processes (B), dendritic
membranes (C), Golgi apparatus (D), mitochondrial membranes (E), and presynaptic vesicles (F) also were observed to have immunoreactivity
compared with respective primary antibody omitted controls. Scale bars = A–B 500 nm, C–F= 100 nm.
doi:10.1371/journal.pone.0014344.g005
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of a long chain fatty acid, most notably palmitic acid [68,69].
Palmitoylation is a covalent attachment of long-chain fatty acids
that increase protein hydrophobicity and membrane association of
proteins [70], such as the estrogen receptor and GR. Recent
analysis [67,69,71,72] suggests that the palmitoylation sequence is
recognized in most steroid receptors, including the GR, proges-
terone, estrogen, and the androgen receptor. If the nuclear
receptors are modified by the lipid moiety, then it is entirely
possible that the membrane receptors are the same as their nuclear
counterparts and function to regulate synaptic excitability.
Although biochemical isolation of mMR remains unconfirmed,
electrophysiological evidence suggests functional synaptic expres-
sion (see [8,14] for thorough reviews). Activation of mMR by low
doses of corticosterone increase the release of glutamate from
presynaptic terminals [10,52] through an extracellular-signal
regulated kinase (ERK) pathway, while at the same time inhibiting
potassium efflux postsynaptically [52]. Fast acting responses after
application of corticosterone has also been found to increase
GluRII subunit motility of the AMPA receptor and may either
enhance or suppress LTP [9,73,74].
Memory acquisition may be differently regulated by mMR and
mGR in the amygdala compared to the hippocampus during an
acute stress. However underlying differences in mechanisms are
not understood. Electrophysiological evidence suggests mMR
enhances whereas mGR inhibits synaptic transmission in the
hippocampus. The activation of the mMR and mGR may be
dependent on the concentration of corticosterone. An inverted U-
shaped dose response has been proposed to describe the
relationship between activation of mMR and mGR and changes
in neuronal excitability [8]. Less characterized is the nongenomic
response of the mMR and mGR in the amygdala. Recent
electrophysiological evidence from the LA suggests greater mMR
relative to mGR activation might modulate AMPA receptor
subunit (GluRII) motility and current [9,73,74]. Although scarce,
results from behavioral studies suggest that activating mMR and
mGR impair working and may impair the consolidation of a fear
memory [17,40,75].
In summary, MR and GR expression in the LA was examined
because the LA is the site of fear memory formation [1,3,76] and
activated mGR and mMR may regulate the acquisition of that
Figure 6. GR and MR labeling at asymmetrical synapses. Asymmetrical synapses were examined for immunoreactivity since
electrophysiological evidence has examined excitatory synaptic responses of MR and GR. Compared with primary antibody omitted control
asymmetrical synapses (A), immunoreactivity was observed in the postsynaptic density of GR-ir LA neurons (B) and MR-ir (MA1–620; rMR1–18 1D5) LA
neurons (C and D, respectively). MR-ir was also observed at presynaptic terminals of asymmetric synapses (D). Scale bar = 100 nm.
doi:10.1371/journal.pone.0014344.g006
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memory [4,7,8,16,17]. MRs were expressed at both nuclear and
extra-nuclear LA structures, including the synapse. These data are
in support of electrophysiological evidence suggesting MR are
functionally positioned to regulate synaptic excitability at synapses
and, in turn, the acquisition of fear memories [5,8,17,18,30,77].
Materials and Methods
Animals
20 male Sprague-Dawley rats with intact adrenal glands were
used in this study (approximately 275–350 g; Taconic Farms,
Hudson, NY). Animals were left with intact adrenal glands in
order to obtain a non-manipulated subcellular anatomical profile
for MR and GR. This has been commonly used in both behavioral
[7,41,42,78] and electrophysiological [10,36,37] studies. All
animals were group housed for 6 days prior to experimentation
with food and water provided ad libitum. Lights were maintained
on a normal light cycle (07:00 until 19:00 h) and the temperature
and humidity were kept at 24uC and 44%, respectively. All animal
procedures related to maintenance and experimentation were in
accord with the National Institutes of Health guidelines and
approved by the Institutional Animal Ethics Committee.
Western Blot Analysis
Three male Sprague-Dawley rats were used in Western Blot
immunoassay analysis. For isolation of total proteins, 25–50 mg
samples of amygdala, hippocampus, and hypothalamus from each rat
were crushed with mortar and pestle in dry ice and dispersed with a
Figure 7. Quantitative analysis of labeling at postsynaptic density of asymmetrical synapses. MR-ir and GR-ir at asymmetrical synapses
was determined using a relative measure of density of pixels at individual asymmetrical synapses. GR-ir and MR-ir labeled asymmetrical synapses had
significantly greater immunoreactivity compared with primary antibody omitted control sections, suggesting the presence of the receptors at the
synapse (A). No differences were found between the two MR-ir groups nor between the MR and GR groups. Two control analysis were utilized to
ensure that the differences in intensity of labeling at the synapses were not due to the intensity of gray of images taken (B) nor to the size of the PSD
(C). (*** depicts p,.001).
doi:10.1371/journal.pone.0014344.g007
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sonicator (Kontes micro-ultrasonic cell disrupter) in lysis buffer
(106PBS, 50 mL; 10% SDS, 5 mL; NP-40, 5 mL; sodium
deoxycholic acid, 2.5 g; and double-distilled water to 500 mL)
containing 16TBS, 0.1% Triton-X-100, and protease inhibitors
(Complete Protease Inhibitor Cocktail Tablets; Boehringer-Mann-
heim, Germany). Lysates were centrifuged at 12,000 rpm for 20 min
at 4uC. Total protein concentrations were determined according to
manufacturer’s instructions (Protein Assay Kit; BioRad).
Twenty-five micrograms of total protein from each sample were
boiled for 5 min then loaded on NuPage Novex 4–12% Bis Tris
gels (Invitrogen, Carlsbad, CA) and separated electrophorectically.
Proteins were transferred to nitrocellulose membranes with the I-
Blot (Invitrogen, Carlsbad, CA). Nitrocellulose membranes were
incubated in blocking buffer (5% dry nonfat milk in Tris-buffered
TBS (TBST): 20 mM Tris-HCL, pH 7.4, 150 mM NaCl, and
0.1% Tween-20) for 1 h followed by incubation in primary
antibodies against the GR (1:200, MA1–510 from Affinity
Bioreagents, Golden, CO) and MR (MA1–620 (1:1000) from
Affinity Bioreagents and rMR1–18 1D5 (1:200) [55], Develop-
mental Studies Hybridoma Bank, Iowa City, IA) overnight at 4uC
on a shaker table. Membranes were washed in washing buffer
(TBST), and then incubated with the appropriate HRP-conjugat-
ed secondary antibody (1:5000) for 60 min at room temperature.
Membranes were then washed and incubated with chemilumines-
cent detection reagents (Pierce, SuperSignal West Femto Maxi-
mum Sensitivity Substrate) for 5 min, and quantified with a Fuji
Film LAS-1000 camera and LAS-1000plus software. Relative
protein levels were determined from the optical densities of the
corresponding protein bands after subtraction of background
values obtained from the same lane. All protein samples were then
standardized with b-actin, an internal control.
Immunohistochemistry Analysis
One week after arrival and habituation to the environment,
animals were deeply anesthetized with between 0.5 and 1.63 mL
chlorohydrate. Animals were then transcardially perfused with
200 mL of physiological saline (0.9% NaCl in distilled H2O) over a
30 sec period followed by perfusion with 200 mL of 4%
paraformaldehyde and 3% acrolein in 0.1 M phosphate buffer
(PB), pH 7.4. Brains fixed for light level analysis were perfused with
200 mL of 1% glutaralydehyde (GLUT) and 4% paraformaldehyde
(PFA). The brains were removed from the skull, washed with PBS,
and post-fixed in 4% PFA and 3% acrolein for 60 min or 4% PFA
and 1% GLUT for 6 hours. Brain slices were sectioned at 30 mm
and placed into one of four conditions. Following blocking with
normal horse serum (Vector Labs, Burlingame, CA) for 60 min,
primary antibodies of GR (MA1–510) and two MR (MA1–620 and
rMR1–18 1D5) were applied for 48 hours at concentrations of
1:100. Additional control samples were incubated in either the
peptide in which the antibody rMR1–18 1D5 was generated (5 mg/
ml) or in 1 mMol aldosterone. This was followed by application of a
biotinylated secondary antibody for 24 hours at a concentration of
1:200 (Vector Labs, Burlingame, CA). Tissue sections were then
incubated in PBS containing bovine serum albumin (ABC) for 60
minutes. The reaction product was visualized by incubation in 3,39-
Diaminobenzidine (DAB) and hydrogen-peroxide [7,79], (Sigma,
St. Louis, MO, USA) for 20 min. Sections prepared for light
observation were visualized by incubation in SG chromogen
(Vector Laboratories, Burlingame, CA) for 6–10 min, washed,
dehydrated, and mounted on gelatin slides. Following application of
2% osmium tetroxide for 20 min, sections prepared for electron
microscopy were post-fixed with 1% uranyl acetate in 70% ethanol,
dehydrated, and placed in resin. Ultrathin sections (85 nm) were
then cut from LA and collected on 6–9 nickel slot grids. For single
labeling (MR-immunoreactive (ir) only or GR-immunoreactive (ir)
only) the primary antibody was omitted and specificity of the
secondary antibody was tested [7]. Control and experimental
sections were incubated and processed for all steps in parallel.
Neuronal cell types and intracellular organelles were examined.
Principal, glutamatergic neurons are morphologically character-
ized based on the presence of smooth non-invaginated oval nuclei
with a thin rim of cytoplasm whereas inhibitory GABAergic
interneurons are characterized as having a round invaginated
nucleus with a thicker rim of cytoplasm [7,80–83]. Somata were
identified by the presence of a nucleus and endoplasmic reticulum;
axon terminals were identified by the presence of synaptic vesicles.
Dendrites were identified by the presence of microtubules,
postsynaptic densities, and the presence of spines [79]. Dendritic
spines were identified as either asymmetric (thickened PSD) or
symmetric (thin or absent PSD) [84]. Glial cells were identified by
irregular contours. Statistical analysis was performed using SPSS
(SPSS, Chicago Il) and included analysis of variance (ANOVA).
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